High preoperative serum alanine transferase levels: Effect on the risk of liver resection in child grade a cirrhotic patients

被引:51
作者
Noun, R [1 ]
Jagot, P [1 ]
Farges, O [1 ]
Sauvanet, A [1 ]
Belghiti, J [1 ]
机构
[1] UNIV PARIS 07,HOP BEAUJON,DEPT HEPATOBILIARY & DIGEST SURG,F-92118 CLICHY,FRANCE
关键词
D O I
10.1007/PL00012259
中图分类号
R61 [外科手术学];
学科分类号
摘要
Despite careful selection of cirrhotic patients with hepatocellular carcinoma (HCC), liver resection remains associated with a greater risk than in patients without underlying liver disease. In this study we assessed by multivariate analysis parameters associated with in-hospital mortality and morbidity in a selected group of 108 Childs-Pugh A cirrhotic patients undergoing liver resection of HCC. The overall incidences of in-hospital deaths and postoperative complications were 8.3% and 48.1%, respectively. By univariate analysis, the preoperative serum alanine transferase (ALT) level (p = 0.001) and intraoperative transfusions (p = 0.01) were significantly associated with in-hospital death; however, only the serum ALT concentration was an independent risk factor. In-hospital mortality rates in patients whose serum ALT was below 2N (twofold the upper limit of the normal value), between 2N and 4N, and more than 4N were 3.9%, 13.0%, and 37.5%, respectively. An ALT level greater than 2N was predominantly observed in patients with a hepatitis C virus infection and significantly associated with histologic features of superimposed active hepatitis. Patients with an ALT level greater than 2N experienced an increased incidence of postoperative ascites (58% versus 32%, p = 0.01), kidney failure (16% versus 0%, p = 0.0003), and upper gastrointestinal bleeding (6.4% versus 0%, p = 0.02). These results indicate that the preoperative ALT level is a reliable predictor of in-hospital mortality and morbidity following liver resection in Child-Pugh A cirrhotic patients. Cirrhotic patients with ALT > 2N should undergo only a limited resection; if a larger resection is required, those patients should be considered for nonsurgical therapy or liver transplantation.
引用
收藏
页码:390 / 395
页数:6
相关论文
共 34 条
[21]  
OKAMOTO E, 1984, SURGERY, V95, P586
[22]  
SHERLOCK S, 1993, DIS LIVER BILIARY SY, P293
[23]  
Sherlock S., 1993, DIS LIVER BILIARY SY, Vninth, P17
[24]   ESTIMATION OF RISK OF MAJOR COMPLICATIONS AFTER HEPATIC RESECTION [J].
SHIMADA, M ;
MATSUMATA, T ;
AKAZAWA, K ;
KAMAKURA, T ;
ITASAKA, H ;
SUGIMACHI, K ;
NOSE, Y .
AMERICAN JOURNAL OF SURGERY, 1994, 167 (04) :399-403
[25]   PERIOPERATIVE PREDICTORS OF MORBIDITY FOLLOWING HEPATIC RESECTION FOR NEOPLASM - A MULTIVARIATE-ANALYSIS OF A SINGLE SURGEON EXPERIENCE WITH 105 PATIENTS [J].
SITZMANN, JV ;
GREENE, PS .
ANNALS OF SURGERY, 1994, 219 (01) :13-17
[26]  
TAKANO S, 1995, HEPATOLOGY, V21, P650
[27]   CAN HEPATIC-FAILURE AFTER SURGERY FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS BE PREVENTED [J].
TAKENAKA, K ;
KANEMATSU, T ;
FUKUZAWA, K ;
SUGIMACHI, K .
WORLD JOURNAL OF SURGERY, 1990, 14 (01) :123-127
[28]   INTRAOPERATIVE RISK-FACTORS ASSOCIATED WITH HEPATIC RESECTION [J].
TANABE, G ;
SAKAMOTO, M ;
AKAZAWA, K ;
KURITA, K ;
HAMANOUE, M ;
UENO, S ;
KOBAYASHI, Y ;
MITUE, S ;
OGURA, Y ;
YOSHIDOME, N ;
BABA, M ;
AIKOU, T .
BRITISH JOURNAL OF SURGERY, 1995, 82 (09) :1262-1265
[29]   INTERFERON FOR NON-A, NON-B CHRONIC HEPATITIS - A METAANALYSIS OF RANDOMIZED CLINICAL-TRIALS [J].
TINE, F ;
MAGRIN, S ;
CRAXI, A ;
PAGLIARO, L .
JOURNAL OF HEPATOLOGY, 1991, 13 (02) :192-199
[30]   RISK-FACTORS FOR HEPATOCELLULAR-CARCINOMA AMONG PATIENTS WITH CHRONIC LIVER-DISEASE [J].
TSUKUMA, H ;
HIYAMA, T ;
TANAKA, S ;
NAKAO, M ;
YABUUCHI, T ;
KITAMURA, T ;
NAKANISHI, K ;
FUJIMOTO, I ;
INOUE, A ;
YAMAZAKI, H ;
KAWASHIMA, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (25) :1797-1801